moxifloxacin has been researched along with hp 873 in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (hp 873) | Trials (hp 873) | Recent Studies (post-2010) (hp 873) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 117 | 17 | 68 |
| Protein | Taxonomy | moxifloxacin (IC50) | hp 873 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.009 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.11 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.009 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0004 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.009 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.11 | |
| D | Mus musculus (house mouse) | 0.75 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.21 | |
| 5-hydroxytryptamine receptor 2A | Bos taurus (cattle) | 0.009 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.064 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for moxifloxacin and hp 873
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |